These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 22172491

  • 1. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM.
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [Abstract] [Full Text] [Related]

  • 2. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P.
    Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
    Li YT, Luo XQ, Zhong XB, Cai LM, Zhu LP, Chen XQ, Wang KC, Chen ZG.
    Vaccine; 2020 May 13; 38(23):3960-3967. PubMed ID: 32321685
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diverse effects on vaccine-specific serum IgG titres and memory B cells upon methotrexate and anti-TNF-α therapy in children with rheumatic diseases: A cross-sectional study.
    Ingelman-Sundberg HM, Laestadius Å, Chrapkowska C, Mördrup K, Magnusson B, Sundberg E, Nilsson A.
    Vaccine; 2016 Mar 04; 34(10):1304-11. PubMed ID: 26827664
    [Abstract] [Full Text] [Related]

  • 9. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul 04; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A.
    An Esp Pediatr; 1999 May 04; 50(5):459-62. PubMed ID: 10394183
    [Abstract] [Full Text] [Related]

  • 12. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H.
    J Infect Dis; 2008 Apr 01; 197(7):950-6. PubMed ID: 18419470
    [Abstract] [Full Text] [Related]

  • 13. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2006 Jan 01; 27(1):63-9. PubMed ID: 16432596
    [Abstract] [Full Text] [Related]

  • 14. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study.
    Kostik MM, Lubimova NA, Fridman IV, Goleva OV, Kharit SM.
    Pediatr Rheumatol Online J; 2021 Jul 05; 19(1):108. PubMed ID: 34225748
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A, Long SS, Lischner HW, Girone JA, Clark JL, Srinivasan R, Maguire TG, Diamond SA, Schiller RP, Rothstein EP.
    Pediatrics; 1988 Feb 05; 81(2):237-46. PubMed ID: 3340474
    [Abstract] [Full Text] [Related]

  • 16. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
    Koochakzadeh L, Khosravi MH, Pourakbari B, Hosseinverdi S, Aghamohammadi A, Rezaei N.
    Pediatr Hematol Oncol; 2014 Oct 05; 31(7):656-63. PubMed ID: 25007393
    [Abstract] [Full Text] [Related]

  • 17. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial.
    Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, Smits GP, van Gageldonk PG, Berbers GA, Wulffraat NM.
    JAMA; 2013 Jun 19; 309(23):2449-56. PubMed ID: 23780457
    [Abstract] [Full Text] [Related]

  • 18. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R, Svensson E, Trollfors B, Borres MP.
    Acta Paediatr; 2004 Sep 19; 93(9):1232-7. PubMed ID: 15384890
    [Abstract] [Full Text] [Related]

  • 19. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA.
    Saudi Med J; 2005 Oct 19; 26(10):1551-4. PubMed ID: 16228054
    [Abstract] [Full Text] [Related]

  • 20. Waning antibody levels and avidity: implications for MMR vaccine-induced protection.
    Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I.
    J Infect Dis; 2012 Nov 15; 206(10):1542-8. PubMed ID: 22966129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.